According to Ramsay Health Care's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 42.5219. At the end of 2022 the company had a P/E ratio of 60.6.
Year | P/E ratio | Change |
---|---|---|
2022 | 60.6 | 110.76% |
2021 | 28.7 | -39.86% |
2020 | 47.8 | 82.62% |
2019 | 26.2 | 1.18% |
2018 | 25.9 | -6.14% |
2017 | 27.6 | -2.83% |
2016 | 28.4 | 0.59% |
2015 | 28.2 | 26.06% |
2014 | 22.4 | 10.95% |
2013 | 20.2 | 55.43% |
2012 | 13.0 | 7.11% |
2011 | 12.1 | -24.73% |
2010 | 16.1 | -10.42% |
2009 | 18.0 | 26.72% |
2008 | 14.2 | -13.66% |
2007 | 16.4 | -16.78% |
2006 | 19.7 | -51.86% |
2005 | 41.0 | 126.81% |
2004 | 18.1 | 36.96% |
2003 | 13.2 | -27.06% |
2002 | 18.1 | -17.25% |
2001 | 21.8 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.